Home Page

Aclaris Therapeutics Submits Investigational New Drug Application for ATI-450, an oral MK2 inhibitor, for the Treatment of Rheumatoid Arthritis

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Aclaris Therapeutics, Inc.

Amicus Therapeutics to Announce First Quarter 2019 Financial Results on May 8, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Amicus Therapeutics, Inc.

NeuroMetrix Reports Q1 2019 Financial Results

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  NEUROMETRIX, INC.

Athenex, Inc. to Report First Quarter 2019 Earnings Results on May 9, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Athenex Inc.

Optinose to Report First Quarter 2019 Financial Results and Corporate Updates on May 9, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  OptiNose US Inc.

Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Immunicum AB

Clearside Biomedical to Report First Quarter 2019 Financial Results and Provide Corporate Update on Wednesday, May 8, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Clearside Biomedical, Inc.

Verona Pharma to Host Investor & Analyst R&D Forum in London on May 8, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Verona Pharma plc

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2019 Earnings and Company Update

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Intellia Therapeutics, Inc.

Evelo Biosciences to Host Quarterly Corporate Update Conference Call on Thursday, May 2, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Evelo Biosciences, Inc.

North Bud Farms Simplifies Trading in the U.S. Market with DTC Eligibility

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Lexington Biosciences to Consolidate its Common Shares

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Commerce Lexington Inc. | Lexington Biosciences, Inc.

CMS’ New Value-Based Payment Program is a Catalyst for Tabula Rasa HealthCare

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Tabula Rasa HealthCare

Cyclerion to Host Corporate Overview Call on May 13, 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Cyclerion Therapeutics, Inc.

miRagen Therapeutics to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8th

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  miRagen Therapeutics, Inc.

IntelGenx to Present at the 2019 Bloom Burton & Co. Healthcare Investor Conference

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  IntelGenx Corp.

The Joint Corp. to Host Conference Call on Thursday, May 9 to Discuss First Quarter 2019 Results

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Philips introduces VitalMinds, new non-pharmacological approach to help reduce delirium in the ICU

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Leading BioSciences to Present at Planet MicroCap Showcase 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  Leading BioSciences Inc.

HOOKIPA Appoints David R. Kaufman to its Board of Directors

Read more ››

By: Nasdaq / GlobenewsWire - 25 Apr 2019

Related companies:  HOOKIPA Pharma Inc.

«  1  2 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »